ketoacidosis

(redirected from diabetic ketoacidosis)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to diabetic ketoacidosis: diabetic diet, diabetic coma

ketoacidosis

[‚kēd·ō‚as·ə′dō·səs]
(medicine)
Mentioned in ?
References in periodicals archive ?
Diabetic ketoacidosis is an emergent condition that occurs in patients with uncontrolled hyperglycemia (elevated blood sugar level) and that can even lead to death.
Diabetic ketoacidosis signs and symptoms often develop quickly, sometimes within 24 hours.
The hospital had been following in-house recommendations for fluids, insulin, and labs for patients with diabetic ketoacidosis that were established in 2006 and 2011.
Patients with diabetes mellitus admitted in IMCU with Diabetic Ketoacidosis was included in the study.
Neonatal diabetes mellitus accompanied by diabetic ketoacidosis and mimicking neonatal sepsis: a case report.
We are reporting a timely case of atypical euglycemic diabetic ketoacidosis in a type 1 diabetic patient treated with sodium-glucose cotransporter-2 (SGLT-2) inhibitor canagliflozin.
Based on the patient's presentation and history, diabetic ketoacidosis (DKA) versus hyperosmolar hyperglycemic syndrome (HHS) was suspected.
VANCOUVER--Transitioning to adult diabetes care tripled hospital admissions for diabetic ketoacidosis in a Canadian study of 147 patients at Western University in London, Ont.
Abdulraof Almahfouz, consultant endocrinologist at King Faisal Specialist Hospital and Research Center, said: "Although a good percentage of our patients can safely fast during Ramadan, namely those who are diet managed or on medication that do not pose significant risk of hypoglycemia and who are otherwise well controlled, others are at moderate to high risk of complications such as hypoglycemia, hyperglycemia, diabetic ketoacidosis dehydration and thrombosis.
They explain the history of insulin therapy, the physiology of insulin secretion and action, insulin types and pharmacokinetics, insulin analogs, advances in delivery devices, insulin therapy in type 1 and 2 diabetes and for diabetic ketoacidosis and the hyperosmolar hyperglycemic state, insulin therapy in hospitalized patients and special situations like renal and liver failure and cancer, and adverse effects.
The reagent can quantifiably detect the presence of ketones in patients with suspected diabetic ketoacidosis.
When treatment with insulin is delayed, patients with type 1 diabetes are at increased risk of a potentially fatal complication diabetic ketoacidosis (DKA), which occurs when the body breaks down fat as an alternative source of fuel in the absence of insulin.